Literature DB >> 27807069

A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers.

Jie Lu1, Mark G Burnett1, Max Shpak2,3,4.   

Abstract

BACKGROUND: Familial cancers are those that co-occur among first-degree relatives without showing Mendelian patterns of inheritance.
MATERIALS AND METHODS: In this analysis, we compare the genomic characteristics of familial and sporadic cancers, with a focus on low-grade gliomas (LGGs) using sequence and expression data from the Cancer Genome Atlas.
RESULTS: Familial cancers show similar genomic and molecular biomarker profiles to sporadic cancers, consistent with the similarity in their clinical features. There are no statistically significant differences among somatic mutation, copy number variant, or gene expression patterns between familial and sporadic cancers; methylation profiles are the only class of molecular data to show significant differences.
CONCLUSION: Familial cancers are likely driven by multiple, individually weak contributions to familiality (i.e. large numbers of alleles and/or shared environmental risks). Consequently, these risk factors tend to be obscured by stronger confounding variables such as clinical or molecular variation among cancer subtypes. Copyright
© 2016, International Institute of Anticancer Research (Dr. John G. Delinasios), All rights reserved.

Entities:  

Keywords:  Familial cancer; cancer risk alleles; gene expression; gene methylation; low-grade glioma

Mesh:

Substances:

Year:  2016        PMID: 27807069      PMCID: PMC5219920          DOI: 10.21873/cgp.20009

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  20 in total

1.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordonna Fulop; Max Liu; Rachel Blanda; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-10-27       Impact factor: 12.300

Review 2.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  Familiality in brain tumors.

Authors:  Deborah T Blumenthal; Lisa A Cannon-Albright
Journal:  Neurology       Date:  2008-09-23       Impact factor: 9.910

4.  Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.

Authors:  Siegal Sadetzki; Revital Bruchim; Bernice Oberman; Georgina N Armstrong; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Christoffer Johansen; Richard S Houlston; Sanjay Shete; Christopher I Amos; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel Lachance; Nicholas A Vick; Ryan Merrell; Margaret Wrensch; Faith G Davis; Bridget J McCarthy; Rose Lai; Beatrice S Melin; Melissa L Bondy
Journal:  Eur J Cancer       Date:  2013-01-04       Impact factor: 9.162

5.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 6.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

7.  Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma.

Authors:  Yanhong Liu; Beatrice S Melin; Preetha Rajaraman; Zhaoming Wang; Martha Linet; Sanjay Shete; Christopher I Amos; Ching C Lau; Michael E Scheurer; Spiridon Tsavachidis; Georgina N Armstrong; Richard S Houlston; Fay J Hosking; Elizabeth B Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Joellen Schildkraut; Siegal Sadetzki; Christoffer Johansen; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel LaChance; Nicholas A Vick; Margaret Wrensch; Faith Davis; Bridget J McCarthy; Ulrika Andersson; Patricia A Thompson; Stephen Chanock; Melissa L Bondy
Journal:  Hum Genet       Date:  2012-06-12       Impact factor: 4.132

8.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

9.  Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.

Authors:  Beatrice Melin; Anna M Dahlin; Ulrika Andersson; Zhaoming Wang; Roger Henriksson; Göran Hallmans; Melissa L Bondy; Christoffer Johansen; Maria Feychting; Anders Ahlbom; Cari M Kitahara; Sophia S Wang; Avima M Ruder; Tania Carreón; Mary Ann Butler; Peter D Inskip; Mark Purdue; Ann W Hsing; Leah Mechanic; Elizabeth Gillanders; Meredith Yeager; Martha Linet; Stephen J Chanock; Patricia Hartge; Preetha Rajaraman
Journal:  Int J Cancer       Date:  2012-11-21       Impact factor: 7.396

10.  Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.

Authors:  Jie Lu; Matthew C Cowperthwaite; Mark G Burnett; Max Shpak
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

View more
  3 in total

1.  Molecular subtyping of tumors from patients with familial glioma.

Authors:  Vanessa Y Ruiz; Corinne E Praska; Georgina Armstrong; Thomas M Kollmeyer; Seiji Yamada; Paul A Decker; Matthew L Kosel; Jeanette E Eckel-Passow; Daniel H Lachance; Matthew N Bainbridge; Beatrice S Melin; Melissa L Bondy; Robert B Jenkins
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 13.029

Review 2.  Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy.

Authors:  Giulia Peppino; Roberto Ruiu; Maddalena Arigoni; Federica Riccardo; Antonella Iacoviello; Giuseppina Barutello; Elena Quaglino
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

3.  Up-Regulation of Hsa-miR-11181 in Glioblastoma Multiforme as A Regulator of AKT2 and TGFBR1 Signalling.

Authors:  Hamed Dabiri; Sadat Dokanehiifard; Bahram Mohammad Soltani; Amin Jahanbakhshi; Mehdi Khaleghi
Journal:  Cell J       Date:  2021-08-29       Impact factor: 2.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.